Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
DFTX
DFTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DFTX News
Helus Pharma Advances New Drug for Anxiety Treatment
1d ago
Newsfilter
Helus Pharma Advances Mental Health Treatments with Promising Phase 2 Results
1d ago
PRnewswire
Definium (DFTX) Q4 2025 Earnings Call Transcript
Feb 27 2026
NASDAQ.COM
Helus Pharma Advances Mental Health Drug Development
Feb 27 2026
Newsfilter
Helus Pharma Advances Psychedelic Drug Clinical Trials
Feb 27 2026
PRnewswire
Definium Therapeutics Q4 2025 Earnings Call Insights
Feb 27 2026
seekingalpha
Definium Therapeutics Completes Key Clinical Trial Enrollments
Feb 26 2026
Yahoo Finance
Definium Therapeutics to Announce Q4 Earnings on February 26
Feb 25 2026
seekingalpha
Definium Therapeutics to Report Financial Results on February 26, 2026
Feb 19 2026
Yahoo Finance
Definium Therapeutics Grants Stock Options to New Employees
Feb 02 2026
Yahoo Finance
Definium Therapeutics Options Risk Analysis
Jan 30 2026
NASDAQ.COM
Definium Appoints Roger Adsett to Board of Directors to Drive Growth
Jan 29 2026
Yahoo Finance
Doseology Sciences Partners with McKinney to Enhance Regulatory Compliance Strategy
Jan 19 2026
Globenewswire
Doseology Sciences Partners with McKinney to Enhance Regulatory Compliance Strategy
Jan 19 2026
Newsfilter
Show More News
